Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

915
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
915
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

419
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
419
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

405
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
405

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous P. lilacinum Hyalohyphomycosis Infection: Atypical Histomorphology in an Immunocompetent Patient.

Journal of cutaneous pathology·2026
Same author

When "Honors" lose their meaning: The ethics of grade inflation in medical education.

Journal of the American Academy of Dermatology·2026
Same author

Rising trends in dermatology publications using large-scale databases.

Clinics in dermatology·2026
Same author

Novel Histopathologic Features of Median Canaliform Dystrophy.

Journal of cutaneous pathology·2026
Same author

Clinician validation of the Medicare measure for potentially avoidable hospital visits after chemotherapy.

Journal of the National Cancer Institute·2026
Same author

Economic and Clinical Value Delivered by Dermatology Trainees From 2016 to 2023.

The Journal of clinical and aesthetic dermatology·2025

Related Experiment Video

Updated: Jan 5, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.5K

Clinical pearl: topical timolol for refractory hypergranulation.

Reid A Waldman, Gloria Lin, Brett Sloan

    Cutis
    |October 12, 2019
    PubMed
    Summary

    Refractory hypergranulation after dermatologic surgery can be difficult to treat. This study explores timolol ophthalmic gel forming solution as a novel, effective treatment for persistent hypergranulation.

    Area of Science:

    • Dermatology
    • Wound Healing
    • Ophthalmology

    Background:

    • Hypergranulation is a common complication following dermatologic surgery.
    • Standard treatments like wound care and silver nitrate are not always effective for refractory cases.
    • Limited therapeutic options exist for persistent postoperative hypergranulation.

    Purpose of the Study:

    • To evaluate the efficacy of timolol ophthalmic gel forming solution for managing refractory hypergranulation.
    • To present an alternative treatment modality for challenging wound healing complications.

    Main Methods:

    • A case study or series describing the application of timolol ophthalmic gel forming solution.
    • Monitoring of wound healing progress and resolution of hypergranulation.
    • Documentation of treatment outcomes and any adverse effects.

    More Related Videos

    Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
    12:25

    Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

    Published on: January 6, 2018

    8.2K
    Induction of Ocular Surface Inflammation and Collection of Involved Tissues
    06:38

    Induction of Ocular Surface Inflammation and Collection of Involved Tissues

    Published on: August 4, 2022

    2.7K

    Related Experiment Videos

    Last Updated: Jan 5, 2026

    Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
    08:30

    Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

    Published on: March 12, 2016

    13.5K
    Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
    12:25

    Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

    Published on: January 6, 2018

    8.2K
    Induction of Ocular Surface Inflammation and Collection of Involved Tissues
    06:38

    Induction of Ocular Surface Inflammation and Collection of Involved Tissues

    Published on: August 4, 2022

    2.7K

    Main Results:

    • Timolol ophthalmic gel forming solution demonstrated effectiveness in resolving refractory hypergranulation.
    • The alternative treatment provided a successful management strategy for previously unresponsive cases.
    • Minimal to no adverse effects were reported with the use of timolol gel.

    Conclusions:

    • Timolol ophthalmic gel forming solution is a viable and effective alternative for treating refractory hypergranulation.
    • This approach offers a new therapeutic option for dermatologic surgeons managing complex wound complications.
    • Further research may validate timolol gel as a standard treatment for such conditions.